SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is seeing immense momentum, driven by its strategic partnership with Crypto.com to enter the burgeoning US prediction markets and sports betting space. This development has sparked widespread community excitement, with traders actively discussing its potential for a significant short squeeze and long-term prospects in the rapidly expanding crypto and gambling sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is highly active as market participants anticipate the outcome of crucial high-level discussions between US and Greenland/Denmark officials regarding Greenland's strategic minerals and geopolitical role. The community is buzzing with speculation around a potential agreement, driving strong discussion of a short squeeze and highlighting the company's recent positive drilling results from its Tanbreez project. This intense focus reflects broader interest in securing critical rare earth element supply chains.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending amid strong investor anticipation for major news, with the community highly focused on its patented Optical Interposer technology as a critical enabler for AI and hyperscale data centers. Discussion highlights the potential for large production orders and strategic partnerships, intensified by recent institutional investments and the Marvell/Celestial AI acquisition as key validators. Despite perceived market manipulation around options expiry, many believe POET is on the cusp of significant growth, poised to revolutionize data transfer efficiency in AI infrastructure.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is actively trending amid discussions about increased capital expenditures for its AI data infrastructure, a concern amplified by recent governmental focus on tech companies covering the full cost of data center energy. While many traders are expressing bearish sentiment and actively shorting the stock, a significant portion of the community sees the current pullback as a compelling buying opportunity, emphasizing Microsoft's strong fundamentals and AI monetization strategy in a volatile mega-cap tech landscape. The ongoing debate centers on the balance between substantial AI investments and their eventual return on investment.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics (VKTX) is trending at the J.P. Morgan Healthcare Conference, fueled by the publication of strong Phase 2 data for its obesity drug VK2735 and remarks from Novo Nordisk's CEO about significant M&A in the weight-loss sector. The community is highly focused on a potential major partnership or acquisition, anticipating FDA clarity on VK2735's oral formulation progressing directly to Phase 3, amidst ongoing debates about its "best-in-class" potential and market valuation. This positions VKTX as a key player in the rapidly expanding and competitive obesity treatment landscape.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

The Metals Company ($TMC) is trending following the White House's approval of NOAA's revised deep seabed mining regulations, a critical development that removes a major procedural bottleneck and accelerates the path to commercial recovery permits. The community is highly bullish, emphasizing this de-risking event and the strategic importance of deep-sea minerals for U.S. independence. This regulatory clarity, combined with recent bullish insider activity, is fueling strong conviction and anticipation of a significant upward repricing among investors.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is actively trending following reports of job cuts within its Reality Labs division, signaling a strategic pivot away from the metaverse while simultaneously emphasizing aggressive long-term investments in AI infrastructure, including a new "Meta Compute" initiative. This reorientation sparks intense debate among investors, with some viewing the efficiency moves and AI focus as a bullish opportunity, while others express concern over continued heavy spending and the stock's underperformance compared to peers in the tech sector.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as users report a significant network outage across various regions, fueling widespread frustration and discussions questioning the reliability of its service. This immediate catalyst amplifies community focus on upcoming corporate results and strategic shifts from its new leadership, particularly concerning the company's competitive standing and the sustainability of its dividend amidst broader market challenges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The biotech sector is abuzz with TG Therapeutics following robust preliminary revenue figures and optimistic guidance for its lead drug, Briumvi, reinforcing its blockbuster potential. Despite the strong performance, community discussion highlights significant frustration over ongoing price volatility and perceived market manipulation, with many questioning why the stock struggles to sustain gains. Amid calls for a potential buyout or aggressive share repurchases, investors are eagerly awaiting further details and clarity on future growth drivers like the subcutaneous formulation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid reports it may switch to an all-cash offer for Warner Bros. Discovery, a move seen by many as a strategic response to ongoing acquisition competition and an upcoming financial report. This potential shift sparks divided community discussion, with some viewing it as a bullish signal for avoiding share dilution and showcasing financial strength, while others express concern over the significant debt implication for the streaming giant.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRMD They have now become a huge BO target...  Unfortunately 15-20 will be the price...

David Howard

Noname2022

Calvin Nguyen

Daniel Willis

Andy

steve mail

InvestorM

StockTwits for iOS

CorMedix Inc

 They have now become a huge BO target...  Unfortunately 15-20 will be the price...

wolfofwestloop

Dr. Evil

Comeasuare

RyGuy

@wolfofwestloop dude. I would fucking kill for $15-20 now wdym unfortunately

Lucas McCain

 dude. I would fucking kill for $15-20 now wdym unfortunately

CRMDepressed

@wolfofwestloop I wish that was the case  but the way it works  he would first get the share price up announcing a buyback it would immediately go to 11+ range

 I wish that was the case  but the way it works  he would first get the share price up announcing a buyback it would immediately go to 11+ range

@wolfofwestloop I’ve said that months ago . If JT is smart he’ll ask for at least 30🙄🤣

 I’ve said that months ago . If JT is smart he’ll ask for at least 30🙄🤣

@wolfofwestloop way too soon for a BO. 2029-2030 with 1-2 billion in revenue from multiple drugs approved in multiple indications. Deerfield wants to make their money. Real money. $20-30 is too small. Tpn around the corner. After that, catheter is a catheter short study for oncology. Rezzayo and everything else. You guys are not patient enough with this company.

Waseem

StockTwits Web

 way too soon for a BO. 2029-2030 with 1-2 billion in revenue from multiple drugs approved in multiple indications. Deerfield wants to make their money. Real money. $20-30 is too small. Tpn around the corner. After that, catheter is a catheter short study for oncology. Rezzayo and everything else. You guys are not patient enough with this company.

Zak Ottow

@GettinIt86 I hope your right...  But I think that&#39;s pie in the sky thinking now.  It&#39;s been 10 yrs of dead money. I don&#39;t think they will wait another 4-5 yrs...

 I hope your right...  But I think that's pie in the sky thinking now.  It's been 10 yrs of dead money. I don't think they will wait another 4-5 yrs...

@wolfofwestloop what strategy mistake has been made or how would you have sped this process up? He doesn&#39;t do the best job communicating.But I don&#39;t see any mistakes with the strategy. Its not a one trick pony anymore. These studies take time and money, so does implementation. Who cares if there is 80 million or 90 or 100 million shares outstanding when Pfizer looks at the  revenue and multiple drugs and pays 15 billion for it.

 what strategy mistake has been made or how would you have sped this process up? He doesn't do the best job communicating.But I don't see any mistakes with the strategy. Its not a one trick pony anymore. These studies take time and money, so does implementation. Who cares if there is 80 million or 90 or 100 million shares outstanding when Pfizer looks at the  revenue and multiple drugs and pays 15 billion for it.

@wolfofwestloop id even take 12$, don&#39;t care anything to get out now

 id even take 12$, don't care anything to get out now

This how companies get taken out.  He&#39;s been unable to produce shareholder value so someone will bang on the door and give them 1.5- 2B and it&#39;s over.  I always thought it would be 4-5B

This how companies get taken out.  He's been unable to produce shareholder value so someone will bang on the door and give them 1.5- 2B and it's over.  I always thought it would be 4-5B